Home > > > Report Detail

Global Gastrointestinal Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 11-Oct-2022
No. of pages: 118
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Gastrointestinal Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Gastrointestinal Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Gastrointestinal Therapeutics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- AbbVie

- Allergan

- Johnson & Johnson

- Takeda

- Novartis

- Pfizer

- Merck

- F. Hoffmann-La Roche

- Eli Lilly

- AstraZeneca

- Procter & Gamble

- Tillotts Pharma

- Takeda

- GlaxoSmithKline

- Amgen

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Gastrointestinal Therapeutics Segment by Type

- Oral

- Parenteral

Gastrointestinal Therapeutics Segment by Application

- IBD

- Irritable Bowel Syndrome (IBS)

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Gastrointestinal Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Gastrointestinal Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Gastrointestinal Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Gastrointestinal Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Gastrointestinal Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche and Eli Lilly, etc.

Global Gastrointestinal Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Gastrointestinal Therapeutics Market Size (2017-2028)
2.2 Gastrointestinal Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Gastrointestinal Therapeutics Market Size by Region (2017-2022)
2.4 Global Gastrointestinal Therapeutics Market Size Forecast by Region (2023-2028)
2.5 Global Top Gastrointestinal Therapeutics Countries Ranking by Market Size
3 Gastrointestinal Therapeutics Competitive by Company
3.1 Global Gastrointestinal Therapeutics Revenue by Players
3.1.1 Global Gastrointestinal Therapeutics Revenue by Players (2017-2022)
3.1.2 Global Gastrointestinal Therapeutics Market Share by Players (2017-2022)
3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gastrointestinal Therapeutics Revenue
3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2021
3.5 Global Gastrointestinal Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gastrointestinal Therapeutics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics Historic Revenue by Type (2017-2022)
4.2 Global Gastrointestinal Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Gastrointestinal Therapeutics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gastrointestinal Therapeutics Revenue by Company (2020-2022)
6.2 North America Gastrointestinal Therapeutics Revenue by Type (2017-2028)
6.3 North America Gastrointestinal Therapeutics Revenue by Application (2017-2028)
6.4 North America Gastrointestinal Therapeutics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Revenue by Company (2020-2022)
7.2 Europe Gastrointestinal Therapeutics Revenue by Type (2017-2028)
7.3 Europe Gastrointestinal Therapeutics Revenue by Application (2017-2028)
7.4 Europe Gastrointestinal Therapeutics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Therapeutics Revenue by Company (2020-2022)
8.2 Asia Pacific Gastrointestinal Therapeutics Revenue by Type (2017-2028)
8.3 Asia Pacific Gastrointestinal Therapeutics Revenue by Application (2017-2028)
8.4 Asia Pacific Gastrointestinal Therapeutics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Revenue by Company (2020-2022)
9.2 Latin America Gastrointestinal Therapeutics Revenue by Type (2017-2028)
9.3 Latin America Gastrointestinal Therapeutics Revenue by Application (2017-2028)
9.4 Latin America Gastrointestinal Therapeutics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Therapeutics Revenue by Company (2020-2022)
10.2 Middle East and Africa Gastrointestinal Therapeutics Revenue by Type (2017-2028)
10.3 Middle East and Africa Gastrointestinal Therapeutics Revenue by Application (2017-2028)
10.4 Middle East and Africa Gastrointestinal Therapeutics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Gastrointestinal Therapeutics Products and Services
11.1.4 AbbVie Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.1.5 AbbVie Gastrointestinal Therapeutics SWOT Analysis
11.1.6 AbbVie Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Gastrointestinal Therapeutics Products and Services
11.2.4 Allergan Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.2.5 Allergan Gastrointestinal Therapeutics SWOT Analysis
11.2.6 Allergan Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Products and Services
11.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.3.5 Johnson & Johnson Gastrointestinal Therapeutics SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastrointestinal Therapeutics Products and Services
11.4.4 Takeda Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.4.5 Takeda Gastrointestinal Therapeutics SWOT Analysis
11.4.6 Takeda Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Gastrointestinal Therapeutics Products and Services
11.5.4 Novartis Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.5.5 Novartis Gastrointestinal Therapeutics SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Gastrointestinal Therapeutics Products and Services
11.6.4 Pfizer Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.6.5 Pfizer Gastrointestinal Therapeutics SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Gastrointestinal Therapeutics Products and Services
11.7.4 Merck Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.7.5 Merck Gastrointestinal Therapeutics SWOT Analysis
11.7.6 Merck Recent Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Products and Services
11.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.8.5 F. Hoffmann-La Roche Gastrointestinal Therapeutics SWOT Analysis
11.8.6 F. Hoffmann-La Roche Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Gastrointestinal Therapeutics Products and Services
11.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.9.5 Eli Lilly Gastrointestinal Therapeutics SWOT Analysis
11.9.6 Eli Lilly Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Gastrointestinal Therapeutics Products and Services
11.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.10.5 AstraZeneca Gastrointestinal Therapeutics SWOT Analysis
11.10.6 AstraZeneca Recent Developments
11.11 Procter & Gamble
11.11.1 Procter & Gamble Company Details
11.11.2 Procter & Gamble Business Overview
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Products and Services
11.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.11.5 Procter & Gamble Recent Developments
11.12 Tillotts Pharma
11.12.1 Tillotts Pharma Company Details
11.12.2 Tillotts Pharma Business Overview
11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Products and Services
11.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.12.5 Tillotts Pharma Recent Developments
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Gastrointestinal Therapeutics Products and Services
11.13.4 Takeda Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.13.5 Takeda Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Products and Services
11.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.14.5 GlaxoSmithKline Recent Developments
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Gastrointestinal Therapeutics Products and Services
11.15.4 Amgen Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022)
11.15.5 Amgen Recent Developments
12 Gastrointestinal Therapeutics Market Dynamics
12.1 Gastrointestinal Therapeutics Market Trends
12.2 Gastrointestinal Therapeutics Market Drivers
12.3 Gastrointestinal Therapeutics Market Challenges
12.4 Gastrointestinal Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Gastrointestinal Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Gastrointestinal Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics Revenue Market Share by Region (2017-2022)
Table 8. Global Gastrointestinal Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics Market Share by Players (2017-2022)
Table 10. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
Table 11. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Gastrointestinal Therapeutics Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2022)
Table 19. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2023-2028)
Table 21. Global Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2022)
Table 23. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2023-2028)
Table 25. North America Gastrointestinal Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Gastrointestinal Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Gastrointestinal Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Gastrointestinal Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Gastrointestinal Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Gastrointestinal Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Gastrointestinal Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Gastrointestinal Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Gastrointestinal Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Gastrointestinal Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Gastrointestinal Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Gastrointestinal Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Gastrointestinal Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Gastrointestinal Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Gastrointestinal Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Gastrointestinal Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Gastrointestinal Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Gastrointestinal Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Gastrointestinal Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Gastrointestinal Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Gastrointestinal Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Gastrointestinal Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Gastrointestinal Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Gastrointestinal Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Gastrointestinal Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Gastrointestinal Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Gastrointestinal Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Gastrointestinal Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Gastrointestinal Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Gastrointestinal Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Gastrointestinal Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Gastrointestinal Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Gastrointestinal Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Gastrointestinal Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Gastrointestinal Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 60. AbbVie Company Details
Table 61. AbbVie Business Overview
Table 62. AbbVie Gastrointestinal Therapeutics Product and Services
Table 63. AbbVie Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 64. AbbVie Gastrointestinal Therapeutics SWOT Analysis
Table 65. AbbVie Recent Developments
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Gastrointestinal Therapeutics Product and Services
Table 69. Allergan Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Allergan Gastrointestinal Therapeutics SWOT Analysis
Table 71. Allergan Recent Developments
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Gastrointestinal Therapeutics Product and Services
Table 75. Johnson & Johnson Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Gastrointestinal Therapeutics SWOT Analysis
Table 77. Johnson & Johnson Recent Developments
Table 78. Takeda Company Details
Table 79. Takeda Business Overview
Table 80. Takeda Gastrointestinal Therapeutics Product and Services
Table 81. Takeda Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 82. Takeda Gastrointestinal Therapeutics SWOT Analysis
Table 83. Takeda Recent Developments
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Gastrointestinal Therapeutics Product and Services
Table 87. Novartis Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Novartis Gastrointestinal Therapeutics SWOT Analysis
Table 89. Novartis Recent Developments
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Gastrointestinal Therapeutics Product and Services
Table 93. Pfizer Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Pfizer Gastrointestinal Therapeutics SWOT Analysis
Table 95. Pfizer Recent Developments
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Gastrointestinal Therapeutics Product and Services
Table 99. Merck Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Merck Gastrointestinal Therapeutics SWOT Analysis
Table 101. Merck Recent Developments
Table 102. F. Hoffmann-La Roche Company Details
Table 103. F. Hoffmann-La Roche Business Overview
Table 104. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Services
Table 105. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 106. F. Hoffmann-La Roche Gastrointestinal Therapeutics SWOT Analysis
Table 107. F. Hoffmann-La Roche Recent Developments
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Gastrointestinal Therapeutics Product and Services
Table 111. Eli Lilly Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 112. Eli Lilly Gastrointestinal Therapeutics SWOT Analysis
Table 113. Eli Lilly Recent Developments
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Gastrointestinal Therapeutics Product and Services
Table 117. AstraZeneca Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 118. AstraZeneca Gastrointestinal Therapeutics SWOT Analysis
Table 119. AstraZeneca Recent Developments
Table 120. Procter & Gamble Company Details
Table 121. Procter & Gamble Business Overview
Table 122. Procter & Gamble Gastrointestinal Therapeutics Product and Services
Table 123. Procter & Gamble Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 124. Procter & Gamble Recent Developments
Table 125. Tillotts Pharma Company Details
Table 126. Tillotts Pharma Business Overview
Table 127. Tillotts Pharma Gastrointestinal Therapeutics Product and Services
Table 128. Tillotts Pharma Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 129. Tillotts Pharma Recent Developments
Table 130. Takeda Company Details
Table 131. Takeda Business Overview
Table 132. Takeda Gastrointestinal Therapeutics Product and Services
Table 133. Takeda Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 134. Takeda Recent Developments
Table 135. GlaxoSmithKline Company Details
Table 136. GlaxoSmithKline Business Overview
Table 137. GlaxoSmithKline Gastrointestinal Therapeutics Product and Services
Table 138. GlaxoSmithKline Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 139. GlaxoSmithKline Recent Developments
Table 140. Amgen Company Details
Table 141. Amgen Business Overview
Table 142. Amgen Gastrointestinal Therapeutics Product and Services
Table 143. Amgen Gastrointestinal Therapeutics Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
Table 144. Amgen Recent Developments
Table 145. Gastrointestinal Therapeutics Market Trends
Table 146. Gastrointestinal Therapeutics Market Drivers
Table 147. Gastrointestinal Therapeutics Market Challenges
Table 148. Gastrointestinal Therapeutics Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics Sales Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Gastrointestinal Therapeutics Sales Market Share by Application: 2021 VS 2028
Figure 5. IBD Case Studies
Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
Figure 7. Gastrointestinal Therapeutics Report Years Considered
Figure 8. Global Gastrointestinal Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Gastrointestinal Therapeutics Market Size 2017-2028 (US$ Million)
Figure 10. Global Gastrointestinal Therapeutics Market Size Market Share by Region: 2021 VS 2028
Figure 11. Global Gastrointestinal Therapeutics Revenue Market Share by Region in 2017 VS 2022
Figure 12. Global Top 10 Gastrointestinal Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
Figure 13. Global Gastrointestinal Therapeutics Market Share by Players in 2021
Figure 14. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2021
Figure 16. North America Gastrointestinal Therapeutics Revenue Market Share by Company in 2021
Figure 17. North America Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2028)
Figure 18. North America Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2028)
Figure 19. North America Gastrointestinal Therapeutics Revenue Share by Country (2017-2028)
Figure 20. U.S. Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 21. Canada Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 22. Europe Gastrointestinal Therapeutics Revenue Market Share by Company in 2021
Figure 23. Europe Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2028)
Figure 24. Europe Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2028)
Figure 25. Europe Gastrointestinal Therapeutics Revenue Share by Country (2017-2028)
Figure 26. Germany Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 27. France Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 28. U.K. Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 29. Italy Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 30. Russia Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Gastrointestinal Therapeutics Revenue Market Share by Company in 2021
Figure 32. Asia Pacific Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2028)
Figure 33. Asia Pacific Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2028)
Figure 34. Asia Pacific Gastrointestinal Therapeutics Revenue Share by Region (2017-2028)
Figure 35. China Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 36. Japan Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 37. South Korea Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 38. India Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 39. Australia Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 40. Taiwan Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 41. Indonesia Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. Thailand Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Malaysia Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 44. Philippines Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 45. Vietnam Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Gastrointestinal Therapeutics Revenue Market Share by Company in 2021
Figure 47. Latin America Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Gastrointestinal Therapeutics Revenue Share by Country (2017-2028)
Figure 50. Mexico Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Gastrointestinal Therapeutics Revenue Share by Country (2017-2028)
Figure 57. Turkey Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 59. UAE Gastrointestinal Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 60. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 61. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 62. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 63. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 66. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 68. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 69. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 70. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 71. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 72. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 73. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 74. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs